Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Adherence to ARV prevention methods is challenging, partly because they don’t treat illness

There are particular challenges to encouraging and accurately measuring adherence in research trials of pre-exposure prophylaxis (PrEP), researchers reported in a series of presentations at

Published
27 May 2010
By
Roger Pebody
Once-a-day treatment: the consequences of poor adherence may be more serious

Although once-a-day treatment regimes can be expected to make adherence easier to handle, if a person does miss doses, the clinical consequences are more serious

Published
26 May 2010
By
Roger Pebody
The perils of success: what if the new prevention methods work?

A debate1 at the International AIDS Society (IAS) Conference in Cape Town in July, sponsored by the IAS and the AIDS Vaccine Advocacy Coalition (AVAC) looked at

Published
01 October 2009
From
HIV treatment update
The perils of success: what if the new HIV prevention methods work?

Within a couple of years’ time, we may know if two crucial new HIV prevention approaches will work. If they do, what then? Who will

Published
04 September 2009
By
Gus Cairns
A jagged little pill: are we prepared for PrEP?

Pre-exposure prophylaxis (PrEP) is the idea of taking HIV drugs in order to avoid being infected with HIV in the first place. We might know if it

Published
01 April 2009
From
HIV treatment update
IAS: PrEP and timed intercourse reduces HIV transmission risk associated with natural conception

Assisted reproduction techniques have been helping mixed-status heterosexual couples conceive safely since 1992. When the male is HIV-positive, this usually involves ‘sperm washing’ and artificial

Published
23 July 2007
By
Edwin J. Bernard

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.